Correlation Between Institute and Centessa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Institute and Centessa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Institute and Centessa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Institute of Biomedical and Centessa Pharmaceuticals PLC, you can compare the effects of market volatilities on Institute and Centessa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Institute with a short position of Centessa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Institute and Centessa Pharmaceuticals.

Diversification Opportunities for Institute and Centessa Pharmaceuticals

0.51

Correlation Coefficient

Institute  Centessa Pharmaceuticals

Very weak diversification

The 3 months correlation between Institute and Centessa is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Institute of Biomedical and Centessa Pharmaceuticals PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centessa Pharmaceuticals and Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Institute of Biomedical are associated (or correlated) with Centessa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centessa Pharmaceuticals has no effect on the direction of Institute i.e., Institute and Centessa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Institute and Centessa Pharmaceuticals

Given the investment horizon of 90 days Institute of Biomedical is expected to generate 4.2 times more return on investment than Centessa Pharmaceuticals. However, Institute is 4.2 times more volatile than Centessa Pharmaceuticals PLC. It trades about 0.09 of its potential returns per unit of risk. Centessa Pharmaceuticals PLC is currently generating about 0.01 per unit of risk. If you would invest  0.49  in Institute of Biomedical on September 13, 2024 and sell it today you would earn a total of  0.19  from holding Institute of Biomedical or generate 38.78% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Institute of Biomedical  vs.  Centessa Pharmaceuticals PLC

Institute of Biomedical

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.

Centessa Pharmaceuticals

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Centessa Pharmaceuticals PLC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Centessa Pharmaceuticals is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Institute and Centessa Pharmaceuticals

The main advantage of trading using opposite Institute and Centessa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Institute position performs unexpectedly, Centessa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centessa Pharmaceuticals will offset losses from the drop in Centessa Pharmaceuticals' long position.

The idea behind Institute of Biomedical and Centessa Pharmaceuticals PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.